These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20571967)

  • 1. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.
    Karray-Chouayekh S; Trifa F; Khabir A; Boujelbane N; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):203-10. PubMed ID: 19657672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
    Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
    Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
    Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
    Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer.
    Wang S; Dorsey TH; Terunuma A; Kittles RA; Ambs S; Kwabi-Addo B
    PLoS One; 2012; 7(5):e37928. PubMed ID: 22701537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
    Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
    World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients.
    Mirza S; Sharma G; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Ann Surg Oncol; 2012 Sep; 19(9):3107-15. PubMed ID: 22451234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.
    Van der Auwera I; Bovie C; Svensson C; Limame R; Trinh XB; van Dam P; Van Laere SJ; Van Marck E; Vermeulen PB; Dirix LY
    Cancer Biol Ther; 2009 Dec; 8(23):2252-9. PubMed ID: 19829046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
    Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
    Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis.
    Wen G; Wang H; Zhong Z
    Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S
    Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
    Brock MV; Gou M; Akiyama Y; Muller A; Wu TT; Montgomery E; Deasel M; Germonpré P; Rubinson L; Heitmiller RF; Yang SC; Forastiere AA; Baylin SB; Herman JG
    Clin Cancer Res; 2003 Aug; 9(8):2912-9. PubMed ID: 12912936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
    Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
    Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.